NABILA SHAD

Allopathic & Osteopathic Physicians|Family Medicine IJAMSVILLE, MD NPI 1891786356

General Payments — all program years on this page

$3,647.73

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 196
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $344.17 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $344.1718

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $533.6037
2019 $658.7033
2020 $199.7312
2021 $541.9131
2022 $535.0927
2023 $834.5338
2024 $344.1718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097044268 Novo Nordisk Inc $16.14 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097739602 Novo Nordisk Inc $15.55 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104512354 AstraZeneca Pharmaceuticals LP $16.81 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105530988 AstraZeneca Pharmaceuticals LP $23.29 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105851732 AstraZeneca Pharmaceuticals LP $14.88 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060802 ABBVIE INC. $22.76 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060804 ABBVIE INC. $18.83 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060806 ABBVIE INC. $18.10 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060808 ABBVIE INC. $24.58 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116346952 GlaxoSmithKline, LLC. $23.11 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116476260 GlaxoSmithKline, LLC. $22.17 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116610424 GlaxoSmithKline, LLC. $21.17 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118221283 Boehringer Ingelheim Pharmaceuticals, Inc. $14.58 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125325582 Abbott Laboratories $17.53 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131698423 PFIZER INC. $22.60 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139272566 Astellas Pharma US Inc $15.71 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139443370 Astellas Pharma US Inc $19.03 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143317123 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.33 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.